tradingkey.logo

Thermo Fisher Scientific Inc

TMO
View Detailed Chart
592.160USD
-15.860-2.61%
Close 01/29, 16:00ETQuotes delayed by 15 min
222.48BMarket Cap
34.17P/E TTM

Thermo Fisher Scientific Inc

592.160
-15.860-2.61%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.61%

5 Days

-7.40%

1 Month

+1.21%

6 Months

+22.81%

Year to Date

+2.19%

1 Year

+4.21%

View Detailed Chart

Key Insights

Thermo Fisher Scientific Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 653.28.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Thermo Fisher Scientific Inc's Score

Industry at a Glance

Industry Ranking
12 / 205
Overall Ranking
74 / 4540
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Thermo Fisher Scientific Inc Highlights

StrengthsRisks
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 44.56B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.
Fairly Valued
The company’s latest PE is 33.30, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 348.50M shares, decreasing 1.45% quarter-over-quarter.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 181.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.04.

Analyst Rating

Based on 29 analysts
Buy
Current Rating
653.279
Target Price
+4.71%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Thermo Fisher Scientific Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Thermo Fisher Scientific Inc Info

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Ticker SymbolTMO
CompanyThermo Fisher Scientific Inc
CEOCasper (Marc N)
Websitehttps://corporate.thermofisher.com/us/en/index.html
KeyAI